# Retraction: Epithelial-Mesenchymal Transition Markers and HER3 Expression Are Predictors of Elisidepsin Treatment Response in Breast and Pancreatic Cancer Cell Lines

PMC · DOI: 10.1371/journal.pone.0298557 · PLOS ONE · 2024-02-05

## Full-text entities

- **Genes:** ERBB3 (erb-b2 receptor tyrosine kinase 3) [NCBI Gene 2065] {aka ErbB-3, FERLK, HER3, LCCS2, MDA-BF-1, VSCN1}
- **Diseases:** Breast and Pancreatic Cancer (MESH:D001943)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC10843617/full.md

## References

1 references — full list in the complete paper: https://tomesphere.com/paper/PMC10843617/full.md

---
Source: https://tomesphere.com/paper/PMC10843617